Literature DB >> 18606975

Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.

Thomas Rudolph1, Martin Wilhelm Kurz, Elisabeth Farbu.   

Abstract

Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of the transthyretin (TTR) gene. Beside polyneuropathy, other complications due to amyloid deposits occur, but may vary in phenotype. The mutation tends to occur in endemic clusters. We describe a 65-year-old man from a non-endemic FAPVal30Met area who developed a progressive generalized painless axonal sensorimotor polyneuropathy with mild autonomic involvement and absent FAP symptoms in the family. Nerve biopsy showed amyloid deposits, staining with TTR-antibodies on immunohistochemistry. After DNA-sequencing of the TTR gene, the diagnosis of FAP Val30Met was made. Late-onset FAP Val30Met is a progressive and fatal disorder with varying penetrance, and may occur in non-endemic areas and cases without a family history.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606975      PMCID: PMC2572554          DOI: 10.3121/cmr.2008.794

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  13 in total

1.  Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.

Authors:  K i Misu; N Hattori; M Nagamatsu; S i Ikeda; Y Ando; M Nakazato; Y i Takei; N Hanyu; Y Usui; F Tanaka; T Harada; A Inukai; Y Hashizume; G Sobue
Journal:  Brain       Date:  1999-10       Impact factor: 13.501

2.  Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence.

Authors:  A Sousa; R Andersson; U Drugge; G Holmgren; O Sandgren
Journal:  Hum Hered       Date:  1993 Sep-Oct       Impact factor: 0.444

Review 3.  A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected.

Authors:  T Coelho; A Sousa; E Lourenço; J Ramalheira
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

4.  Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy.

Authors:  P Lindqvist; B O Olofsson; C Backman; O Suhr; A Waldenström
Journal:  Eur J Echocardiogr       Date:  2006-01

5.  Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.

Authors:  Haruki Koike; Ken-ichiro Misu; Shu-ichi Ikeda; Yukio Ando; Masamitsu Nakazato; Eiko Ando; Masahiko Yamamoto; Naoki Hattori; Gen Sobue
Journal:  Arch Neurol       Date:  2002-11

6.  Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25.

Authors:  Masahide Yazaki; Taro Yamashita; John C Kincaid; John R Scott; Raymond G Auger; Peter J Dyck; Merrill D Benson
Journal:  Muscle Nerve       Date:  2002-02       Impact factor: 3.217

7.  Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.

Authors:  Miguel L Soares; Teresa Coelho; Alda Sousa; Serge Batalov; Isabel Conceição; Maria L Sales-Luís; Marylyn D Ritchie; Scott M Williams; Caroline M Nievergelt; Nicholas J Schork; Maria João Saraiva; Joel N Buxbaum
Journal:  Hum Mol Genet       Date:  2005-01-13       Impact factor: 6.150

Review 8.  Cellular consequences of transthyretin deposition.

Authors:  Maria J Saraiva
Journal:  Amyloid       Date:  2003-08       Impact factor: 7.141

9.  Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.

Authors:  Ole B Suhr
Journal:  Amyloid       Date:  2003-08       Impact factor: 7.141

10.  Haplotype analysis of common transthyretin mutations.

Authors:  M R Almeida; N Aoyama-Oishi; Y Sakaki; G Holmgren; D Ulf; A Ferlini; F Salvi; M Munar-Oués; M D Benson; M Skinner
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

View more
  3 in total

Review 1.  The genetics of cardiac amyloidosis.

Authors:  Scott Arno; Jennifer Cowger
Journal:  Heart Fail Rev       Date:  2021-09-13       Impact factor: 4.654

2.  Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.

Authors:  Gonçalo da Costa; Ricardo A Gomes; Ana Guerreiro; Élia Mateus; Estela Monteiro; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

Review 3.  Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.

Authors:  Márcia Waddington-Cruz; Hartmut Schmidt; Marc F Botteman; John A Carter; Michelle Stewart; Markay Hopps; Shari Fallet; Leslie Amass
Journal:  Orphanet J Rare Dis       Date:  2019-02-08       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.